becton dickinson co
publish updat model ahead print initi
guidanc next week account recent divestitur bioprocess
busi recent fx-relat develop ep move
revis maintain buy pt
model updat updat model tweak revenue/ep forecast
ahead print initi guidanc next week account impact
recent divestitur advanc bioprocess unit rev
ep impact fx accordingli trim ep
expect strong finish year core growth ep
unchang step back remain construct stock view
rel safe choppi healthcar tape valuat back reason
level trade price-to-earnings discount larg cap med-tech comp average
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
nopat compound-annual-growth-rate next decad
realiz bcr-relat cost synergi
yr
price multipl ep ev
see compel defens larg cap
hold given abil drive durabl core
growth mid-teen ep growth thru still
support dividend continu success
revenue/cost synergi integr bard
paramount stock move
organ revenu growth new product
realiz bcr-relat cost synergi
page
pleas see import disclosur inform page report
